Rift widens in KPMA

Published: 2012-04-19 07:00:00

Updated: 2012-04-19 07:00:00

The leadership of the Korea Pharmaceutical Manufacturers Association (KPMA) is facing a backlash from within over the rumors that the second pharmaceutical body is to be established under the full support from the Ministry of Knowledge Economy (MKE).

So far, incumbent KPMA president Yoon Suk-g...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK